Please login to the form below
recalls
This page shows the latest recalls news and features for those working in and with pharma, biotech and healthcare.
The mother of all nudges
You may recall that a few months ago (in PME, October 2019) I wrote a column about externalities and their importance in the context of public health.
Latest news
-
Trump administration advances drug importation plan
The proposal could prove difficult for other reasons, as it also requires importers to have knowledge of regulatory processes – including safety tests and being able to manage product recalls.
-
Brexit nears as Conservatives sweep to victory in election
Recall just before the 2016 vote he publicly backed staying in the single market, which would solve the Irish border problem at a stroke.
-
J&J to FDA: there really is no asbestos in Baby Powder
Tests were also done on three lots manufactured before and after the recall, but were also negative, says J&J. ... The recall of the lot (#22318RB) will however stay in effect as it is ‘not feasible’ to halt it, according to J&J.
-
The Unhappiness Project
I cannot recall a single chronic patient that I have ever met who has raved about the health system and how efficiently it operates.
-
GSK and Apotex join generic Zantac recalls as carcinogen concerns mount
Now GlaxoSmithKline, the original branded manufacturer of Zantac, has stopped global distribution of the medicine, and will recall the drug in India and Hong Kong. ... The FDA and other global health regulators are continuing to test different ranitidine
More from news
Approximately 10 fully matching, plus 189 partially matching documents found.
Latest Intelligence
-
Medicinal data – what’s next for IDMP?
Managing recalls is often a particularly painful reminder of the need for greater information visibility and product traceability.
-
Achieving an agile supply chain
Similarly, a major beverage company – where gaps in coding processes had previously led to a $40, 000 recall – completely removed human intervention failures with the introduction of integrated automation, mitigating production
-
The pandemic preparedness paradox
and the seller has captured a large and negative return (recall, the cost of development is fixed).
-
Health trust in a COVID-19 world – a unique opportunity for pharma
This, you may recall, is the group which makes up 17% of the total global population.
-
COVID-19 hits supply chains
Eban’s best-selling exposé, Bottle of Lies, describes how substandard manufacturing conditions traced to Chinese facilities led to drug recalls and patient deaths. ... The valsartan recall was particularly dismaying because a year prior to that, an
More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.
Latest appointments
-
J&J appoints Bayer’s Sandra Peterson as group worldwide chair
by recalls and quality control problems these past two years.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: What's missing in women's health?
31. Transvaginal Mesh Recalls, Discontinued Products &FDA Regulation. Drug. Watch. https:// www.drugwatch.com/transvaginal-mesh/recall/.
-
Changing healthcare, one film at a time
Emotionally resonant content is also linked with improved attention and recall, two crucial aspects of any effective healthcare communications campaign.
-
WHITE PAPER: Marketing fulfilment – a balancing act
4. Are you ready for anything? How ready are you for a recall? ... As with any element of crisis management, it’s worth establishing a process for handling marketing collateral in case of a recall.
-
Experiential Marketing
At the beginning of this post, I asked you to recall a favourite day.
-
Secrets of Pharma Advertising
Ask someone to unpick an ad for a new dermatology product, and they will compare it to other dermatology ads they recall, expressing confusion at anything that looks different.
More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- GSK discontinues two feladilimab trials in head and neck cancer
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- Live Webinar: Advancing Human Health Through Precise Measures of Movement, Cognition & Biometrics
- Live Webinar: How to Simplify Genetics & Raise Awareness Around Orphan Diseases
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
